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Motor neurone disease (MND) is a devastating condition. This preliminary study aims to identify relevant personal factors
aﬀecting the experience of living with MND from the perspective of persons with MND (pwMND) in an Australian cohort.
A prospective cross-sectional survey of pwMND (n = 44) using an open-ended questionnaire identiﬁed personal factors that
were categorised thematically. Standardised questionnaires assessed disease severity: depression, anxiety, and stress and coping
strategies. Personal factors identiﬁed included demographic factors (socioeconomic status), emotional states (depression, anxiety,
and fear), coping strategies (problem-based coping and denial), personality, beliefs (religious and personal values), attitudes (of
the patient), and others (such as perceived support). An understanding of personal factors by treating clinicians is essential in
the provision of optimal care in MND. This study may assist in the development of personal factors within the International
Classiﬁcation of Functioning, Disability, and Health for improved consensus of care and communication amongst treating
clinicians.
1.Introduction
Motor neurone disease (MND) (amyotrophic lateral scle-
rosis) is a relatively rare neurodegenerative disorder of the
motor system in adults characterized by the loss of motor
neurons in the cortex, brain stem, and spinal cord, mani-
festedbyupperandlowermotorneuronsignsandsymptoms
aﬀectingbulbar,limb,andrespiratorymuscles.Deathusually
occursthree-to-ﬁveyearsafteronsetfromrespiratoryfailure,
b u ts o m em a ys u r v i v ef o rad e c a d eo rm o r e[ 1]. The burden
of disease and economic impact of MND upon patients,
their caregivers (often family members), and on society is
substantial. It often begins long before the actual diagnosis
is made and increases with increasing disability and the need
for medical equipment and assisted care [2].
With no cure currently available, the challenge in MND
is to prolong independence, prevent complications, and
optimise quality of life (QoL). This is best met by a multidis-
ciplinary team with a focus on symptomatic, rehabilitative,
and palliative care [3, 4], through holistic interventions
(incorporate personal and environmental factors) that span
the spectrum of the disease. A signiﬁcant part of the pal-
liative rehabilitation process is the self-empowerment of
patients and their families and helping them adapt as the
disease progresses. Personal factors, which are deﬁned as the
particular background of a person’s life and living which
are not part of a health condition [5], can be important
barriers and/or facilitators to this process, and rehabilitation
oftenaimstoenhancefacilitatingfactorswhilstunderplaying
the negative factors to achieve the most optimal functional
and social reintegration outcomes. For example, education
(for patients and families) is an integral part of MND
management,butinformationprovidedmustbeappropriate
to the patient’s educational level; timing of end-of-life issues
depend on a number of factors including coping skills,
depression and anxiety, cultural issues, and functional status
[6]; technological aids (which can vary considerably in
cost) need to suit the patient’s socioeconomic status, which
impacts on their ability to fund these aids.
The International Classiﬁcation of Functioning, Disabil-
ityandHealth(ICF)[5]aimst od ev elo pac o mmo nlanguag e
for describing the impact of a disease at diﬀerent levels.2 Rehabilitation Research and Practice
Within the ICF classiﬁcation, MND-related impairments
(muscle weakness) can limit “activity” (reduced mobility
and self care) and “participation” (work, family, and social
reintegration). The ICF also acknowledges that environmen-
tal factors (physical, social, and attitudinal environment in
which people live and conduct their lives) and personal
factors (intrinsic inﬂuences such as race, gender, and coping
styles) interact with all the other constructs within the ICF
to aﬀect the person’s overall experience of living with their
condition. A set of relevant ICF categories in MND would
be useful in both clinical and research settings given the rare
incidence of MND and diverse and challenging nature of the
symptoms. It has been also been highlighted that current
o u t c o m em e a s u r e sd on o tc a p t u r et h ee n t i r es p e c t r u mo f
issuesinMND[7];useoftheICFcategoriescouldcontribute
towards development of appropriate outcome measures for
MND. However, at present, personal factors are not classiﬁed
in the current version of ICF, which represents a signiﬁcant
gap in the overall biopsychosocial view of the condition.
This preliminary study aims to identify the personal
factors that are relevant in persons with MND from their
perspective, in an Australian cohort.
2. Methods
2.1. Participants and Setting. A community-based MND
group was recruited through a tertiary MND multidisci-
plinary clinic that services Victoria, Australia, including
metropolitan and rural regions. Selection criteria included
diagnosis of MND according to the El Escorial criteria [8]
as diagnosed by a neurologist, residence in Victoria, com-
munitybased(nonhospitalinpatient),abilityandwillingness
to give informed consent. Exclusion criteria included severe
cognitive issues or dementia and other substantial medical,
neurological, or psychiatric disorders. Screening of exclusion
criteria was done by a neurologist through consultation of
the medical records and liaison with the treating clinicians
of the patients. This study was approved by the Melbourne
Health and Calvary Healthcare Bethlehem Human Research
and Ethics Committees.
All participants (n = 59) who met the criteria were con-
tacted by mail and invited to participate in the study. Those
who replied aﬃrmatively (n = 44) were contacted by tele-
phone by the primary author who explained the study fur-
ther and organised an interview appointment. Participants
were interviewed at a venue of their choice (half were inter-
viewed at home or at hospital and half over the telephone)
for one hour with rest breaks.
2.2. Questionnaires. Interviews commenced with an open-
ended self-report questionnaire. Participants were asked,
“What are the main problems you face in your everyday
life? If possible, can you list and prioritize up to 10 issues
that you feel are the most pressing problems you face in
everyday life?” Participants were asked to include intrinsic
factors that impacted on their experience of these problems,
such as their ability to cope. Some who had diﬃculties with
verbal communication chose to write their responses and/or
use communication devices.
From the participant responses (from the open-ended
questionnaire),allproblemsrelatingtopersonalfactors(cur-
rently not coded within the ICF) were grouped under
“personal factors” and categorized thematically under major
headings, which included demographic factors (gender, race,
age, and educational status), emotional states (depression,
stress, anxiety, and fear), coping strategies and styles (prob-
lem-based coping and denial), personality, beliefs (includes
self-eﬃcacy, religious beliefs and values, personal and cul-
tural), attitudes (of the patient), and “other” (perceived
social support). Reports unrelated to personal factors have
not been included in this paper as they are not the primary
focus.
Self-administered (patient) questionnaires followed the
open-ended questionnaire:
(a) sociodemographic and medical status questionnaire,
(b) amyotrophic lateral sclerosis functional rating scale
(ALSFRS)[9]todetermineseverityofMND.Thisisa
48-pointmeasureofdisabilityinMNDwithexcellent
validity and reliability and can be administered over
the phone. It is determined by scoring 0–4 for each of
the twelve domains (speech, salivation, swallowing,
handwriting, cutting food and handling utensils,
dressing and hygiene, turning in bed and adjusting
bed clothes, walking, climbing stairs, dyspnoea, or-
thopnea,andrespiratoryinsuﬃciency).Alowerscore
indicates more disability,
(c) depression, anxiety, and stress scale (DASS) [10], a
21-item instrument with acceptable to excellent in-
ternal consistency and concurrent validity, consisting
of three 7-item self-report scales designed to measure
the negative emotional states of depression, anxiety,
and stress. Participants rate the extent to which they
experienced each state over the past week on a 4-
point Likert rating scale,
(d) brief COPE [11], a coping inventory, with good re-
liability and validity, of 14 subscales (active coping,
planning, positive reframing, acceptance, humour,
religion, using emotional support, using instrumen-
tal support, self-distraction, denial, venting, sub-
stance use, behavioural disengagement, and self-
blame) measuring responses relevant to eﬀective and
ineffective coping.
Assistance was provided where necessary by the inter-
viewer and all patient responses were clariﬁed where possible
with their caregivers.
2.3. Statistical Analysis. Results were described by mean and
standard deviation (SD) for continuous nonskewed data
and as frequency (%) for categorical data. Each identiﬁed
personal factor was listed once regardless of the frequency of
identiﬁcation either by a single or multiple participant(s) for
simplicity.Rehabilitation Research and Practice 3
3. Results
Mean age of participants was 61 years (SD 9.8), and male:
female ratio was 3:2. Mean time since diagnosis was 3.6
years. Half (n = 18, 41%) of the participants had severe
disease as classiﬁed by ALSFRS (ALSFRS 0–24) (see Table 1).
Participants appeared grossly cognitively intact based on
simple observation during the interviews. Personal factors
identiﬁed that were relevant in persons with MND to the
experience of their condition are listed in Table 2.S o m ef a c -
tors crossed over two categories. For example, “self-esteem”
encompassed both a belief (that the patient was worthy)
and an emotion (of pride) and is, therefore, listed under
both categories. A signiﬁcant proportion of the participants
were depressed (n = 19, 43%), anxious (18, 41%) and/or
stressed (11, 25%) and problem focused coping strategies
were used much more commonly than emotion-focused
coping strategies (see Table 3).
4. Discussion
This is the ﬁrst study that has identiﬁed personal factors that
shape a person with MND’s experience of their condition.
These factors include demographic factors (gender, race, age,
educational status, and socioeconomic status), emotional
states (depression, stress, anxiety, and fear), coping strategies
and styles (problem-based coping and denial), personality,
b e l i e f s( i n c l u d e ss e l f - e ﬃcacy, religious beliefs, and personal
values), attitudes (of the patient) and “other” (perceived
social support). Rates of depression and anxiety were high
and a broad range of coping strategies were used although
problem-focused coping strategies were preferred. The mean
participant age, gender, time since diagnosis, distribution of
type, and severity of disease (based on ALSFRS-R) were sim-
ilar to those reported by others [12]. The participants repre-
sented a broad range of disability and disease severity, with
demographic and diagnostic characteristics typical of MND.
These ﬁndings (of depression, anxiety, and a range of
coping strategies) and the identiﬁed personal factors are
consistent with other reports in MND literature. Rates of
depression and anxiety are reported to be 0–44% and 0–
30%, respectively, in persons with MND [13]. This is not
surprising given the progressive and fatal nature of their dis-
ease.However,itisalsogenerallythoughtthatdespitedisease
progression, most MND patients adjust eﬀectively to their
illness and in fact are often perceived to be particularly posi-
tive people [14]. The impact of personal factors on the lived
experience and QoL of MND should not be underestimated.
It has been previously reported that QoL appears to be more
dependent on “psychological and existential issues, social
support and spirituality” rather than physical factors [15].
These ﬁndings were supported by Chi` o et al. [16] who found
that the main determinants of quality of life in MND were
social support, depression, religiosity, and socioeconomic
status. More recently, Roach et al. concurred that it was likely
that characteristics such as personality, social relationships,
and spirituality could be more important for QoL [17] than
progression of the disease per se. The importance of coping
strategies in the experience of MND is further supported
Table 1:Characteristicsofmotorneuronedisease/amyotrophic lat-
eral sclerosis (MND/ALS) participants—demographics and disease
features.
Variable Average/Frequency
Age (mean ± SD (range) 61 ±9.8 (43–80)
Sex [n (%)]
Male 29 (65.9)
Female 15 (34.1)
Marital status (n,% )
Married/partner 34 (77.3)
Divorced/separated/single 10 (22.7)
Race (n,% )
Caucasian 44 (100%)
Living [n (%)]
Alone 8 (18.2)
Family 36 (82.8)
Geographical area
Metropolitan [n (%)] 27(61.4)
Rural [n (%)] 17 (38.6)
Diagnosis of ALS (El Escorial criteria) [n
(%)]
Clinically deﬁnite ALS 14 (31.8)
Clinical probable ALS 17 (38.6)
Probable ALS (Lab Supported) 5 (11.3)
Possible ALS 4 (9.1)
Suspected ALS 4 (9.1)
Amyotrophic lateral sclerosis functional
rating scale-revised (ALSFRS—R [n (%)]
0–12 3 (6.8)
13–24 15 (34.1)
25–36 12 (27.3)
37–48 14 (31.8)
Comorbidities (n,% )
Yes 28 (63.6)
None 16 (36.4)
≥2 comorbidities 14 (50.0)
Clinical symptoms (n,% )
Fatigue 34 (77.3)
Pain 22 (50.0)
Spasticity/cramps/spasms 32 (72.7)
Emotional lability 21 (47.7)
Shortness of breath 8 (18)
by Gallagher and Monroe [18] who surmised that MND is
not a static disease but a progressive disorder that required
diﬀerent coping strategies at diﬀerent stages of the disease.
Matuz et al. [14] also found that the best predictors for
the severity of depressive symptoms in MND were perceived
social support (especially a supportive marital relationship)
and coping potential (information seeking and strategies of
emotional avoidance behaviour). For example, a combina-
tion of confronting and avoiding coping strategies might be4 Rehabilitation Research and Practice
Table 2: Personal factors reported by participants with motor
neurone disease (MND) which aﬀected their experience of living
with MND.
Personal factors category Personal factors examples
Demographic factors
Gender
Race
Age
Educational status
Socioeconomic status
Emotional states
Frustration
Depression
Stress
Anxiety
Fear
Worry
Degrading
Grumpy
Loss of conﬁdence
Anger
Self-esteem
Embarrassment
H o p e( b o t hh o p e f u la n dh o p e l e s s )
Guilt
Grief
Loss
Gratitude
Coping strategies and styles
Problem solving
Search for information
Planning
Positivity
Acceptance
Humour
Religion
Using support
Denial
Avoidance
Personality Stubborn
Easy-going
Beliefs Religious beliefs
Self-esteem
Attitudes (of the patient)
Grateful attitude (towards family
and health professionals)
Fighting attitude
Attitude towards assisted suicide
Being organised
“Other” Perceived support
useful for MND patients, because search of information and
supportmayhelpthemtoinitiateactionsthatensureoptimal
future care [14]. On the other hand, emotional avoidance
behaviour (e.g., choosing isolation or denial) could protect
Table 3: Results of depression, anxiety, and stress scale (DASS) and
brief COPE.
DASS [n,( % ) ]
DASS Depression
Normal 25 (56.8%)
Mild 9 (20.5)
Moderate 4 (9.1%)
Severe 3 (6.8%)
Extreme 3 (6.8%)
DASS Anxiety
Normal 26 (59.1%)
Mild 6 (13.6%)
Moderate 4 (9.1%)
Severe 4 (9.1%)
Extreme 4 (9.1%)
DASS Stress
Normal 33 (75.0%)
Mild 6 (13.6%)
Moderate 2 (4.5%)
Severe 3 (6.8%)
Extreme 0
Brief COPE variables Mean (SD) Range
Problem focused coping strategies
Active coping (2–8) 6.3 (1.6) 2–8
Planning (2–8) 6.2 (1.7) 2–8
Positive reframing (2–8) 6.0 (1.8) 2–8
Acceptance (2–8) 7.4 (1.1) 2–8
Humour (2–8) 5.0 (2.4) 2–8
Religion (2–8) 4.0 (2.3) 2–8
Using emotional support (2–8) 6.3 (1.5) 3–8
Using instrumental support (2–8) 5.7 (1.7) 2–8
Emotion-focused coping strategies
Self-distraction (2–8) 5.7 (2.0) 2–8
Denial (2–8) 2.9 (1.4) 2–8
Venting (2–8) 3.6 (1.6) 2–8
Substance use (2–8) 2.7 (1.5) 2–8
Behavioural disengagement (2–8) 2.8 (1.4) 2–7
Self-blame (2–8) 2.7 (1.0) 2–6
them from psychological distress and despair [19]. However,
as the disease progresses, avoidance is no longer an adaptive
strategy, as it prevents patients from taking appropriate
measure to cope further with the illness [14].
Personality appears to be another personal factor that
plays a signiﬁcant role in the experience of MND. It has
been found that MND patients (n = 31) who scored higher
on the agreeableness personality dimension had higher QoL
initially, but the reduction of QoL over 12 months was
signiﬁcantly steeper than in patients who scored lower on
agreeableness, suggesting that being less agreeable might
serve as a protective factor with respect to QoL [20]. Nelson
et al. [21] reported that personality traits such as optimism,
ﬂexibility, and humor were important in coping. As forRehabilitation Research and Practice 5
beliefs, it has been reported that the belief that fate controls
one’s health and a person’s belief in “powerful others”
such as doctors changes with disease progression in MND
[22]. Interestingly, no cultural beliefs were mentioned in
this cohort, possibly because of the homogeneity in race
(100% Caucasian) in this cohort, but religious beliefs were
frequently mentioned, consistent with the high proportion
(64%) of Christianity practiced in Australia [23]a n dw i t h
previous reports that religion is one of the most important
coping mechanisms in a fatal disease such as MND [24].
Finally, other studies have reported that the most important
personal values in MND patients were benevolence, self-
direction, and universalism [25] .T h e s ev a l u e sw e r en o ts p e -
cifically explored in this cohort.
Under the UK Department of Health’s National Service
Framework for Long-term Neurological Conditions [26],
MND is a “progressive condition” with a rapid deteriorating
course. Multiple sclerosis is another long-term progressive
neurological condition but with a more “intermittent,” slow-
ly “progressive” or “stable” nature. Comparison of relevant
personal factors in MND with other “long-term neurological
conditions” is challenging as it diﬀers from other conditions
inthatthereisconstantdeteriorationand,therefore,ongoing
“change and adaptation” [27]. It is also unique in that given
the limited life span, changes in personal factors can be stud-
ied through the entire spectrum of the disease, as described
above.Therearefewotherreportsrelatingtopersonalfactors
in other long-term neurological conditions. In identifying
the ICF core set for multiple sclerosis, Khan and Pallant [28]
suggested ten categories which included socioeconomic sta-
tus, coping ability, attitudes and patient beliefs, self-eﬃcacy,
dependence on others, mood and aﬀect, heat intolerance,
fatigue, personality and temperament, and patient attitude
towards the biopsychosocial impact of multiple sclerosis.
Many of these are comparable with this MND cohort.
Other reports have shown that in both MND and multiple
sclerosis, psychological adaptation to deteriorating function
is an important factor in perceived QoL and emotional well-
being [29]. The impact of personal factors on participation
in the rehabilitative process in other neurological conditions
has also been emphasized—a recent study showed that
rehabilitationprofessionalsattemptingtoengagepeoplewith
multiple sclerosis in a physical activity programme needed
to consider adopting an individualised approach to barrier
management which takes into account personal beliefs and
perceptions regarding physical activity engagement [30].
Hence, despite some of the unique features of MND, many
of the ﬁndings in this study are likely to be relevant to other
neurological conditions.
MND takes its toll on the patient and family especially as
the disease progresses and loss of independence occurs. Un-
derstanding the personal factors involved helps with the pal-
liative rehabilitation process. As part of this process, advice
with regards to adequate coping strategies and provision of
an adequate amount of disease- and support-related infor-
mation at any one time and encouraging patients to seek
social support [14]i sc r u c i a l .H e n c e ,r e f e r r a l st os u p p o r t
groups and counselling and education of patients and their
families (often their caregivers) are important. Subgroups
of patients who are more likely to adapt poorly to a new
diagnosis of MND can also be identiﬁed early with explo-
rative interviews that speciﬁcally target coping, depression,
anxiety, social withdrawal, and quality of life [31]. Targeted
earlier intervention can be provided for this subgroup.
Frank discussions facilitate understanding of the disease
and improve coping skills. Referrals to the local MND as-
sociations are also recommended as these provide patients
and families with ongoing support, resources and equipment
needs. Psychotherapy should also be considered to assist
with coping strategies [14] and antidepressants may be used.
Anxiety is diﬃcult to measure due to physical confounding
symptoms such as shortness of breath, muscle cramps, and
restlessness. Anxiety can be treated with psychotherapy and
training in relaxation and breathing techniques as well as
participation in support groups. With good support, mental
health and quality of life can remain stable despite deterio-
rating physical health [32]. In addition, an often-neglected
part of rehabilitation in MND is support for continuation
of work [33]. Understanding personal factors can help target
thesubgroupofMNDpatientswhowishtocontinuework—
it has been found that intrinsic reasons (motivation resulting
from a person’s interest in and enjoyment of the work),
followed by age, disability severity, and accessibility of travel
[34] are the strongest predictors for this group.
The limitations in this study include cross-sectional
survey (no longitudinal information), highly selective cohort
(allalreadyreceivingtertiarymultidisciplinarycare,andwill-
ing research participants). Interviews were challenging given
the fragile emotional and physical status of the participants.
Self-reported information was used and validated as best
with caregiver and medical records. The cohort covers a wide
geographical population in Victoria and is representative of
the wider sample of pwMND.
MND is a devastating illness for patients and families.
Palliative care and rehabilitation has much to oﬀer this pop-
ulation.Forimprovedconsensusofcareandcommunication
amongst treating clinicians, the framework of ICF should be
explored in this population and further expanded to take
into consideration individual personal factors which impact
signiﬁcantly upon the experience of illness and the rehabil-
itation process. This preliminary study identiﬁes intrinsic
factors reported by patients with MND and may be the ﬁrst
step in the development of personal factors within the ICF
classiﬁcation.
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